A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

Clinical trial NCT02087176 · TERMINATED

Trial details

NCT number: NCT02087176
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Previously Treated Non Small Cell Lung Cancer

Start date: 2014-03-01
Primary completion: 2015-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.